Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Alpha Cognition Inc
ACOG
Healthcare
Biotechnology
Alpha Cognition Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company’s pipeline includes ALPHA-1062, ALPHA-0602, and ALPHA-0702 and ALPHA-0802 (GEMs). The Company’s ALPHA-1062...
is a patented new chemical entity being developed as a new generation acetylcholinesterase inhibitor for the treatment of Alzheimer's disease, with expected minimal gastrointestinal side effects. ALPHA-1062 is also being developed in combination with memantine to treat moderate to severe Alzheimer’s dementia, and as an intranasal formulation for Cognitive Impairment with mTBI. ALPHA-0602 is a gene therapy program delivering progranulin, a neurotrophic protein. It is in preclinical development for the treatment of ALS.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ACOG)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
(273)
•••
partystocker
X
View Profile
View Bullboard History
Post by
partystocker
on Nov 29, 2021 2:54pm
$ACOG Testing Resistance up ~5% On the Day So Far
Alpha Cognition $ACOG/$ACOG.V is testing support at $1.12 today and I’m looking for a break above the current bearish trend as shares are up ~5% today. The RSI and Stochastic oscillator are currently
...more
(144)
•••
culturedpiggy01
X
View Profile
View Bullboard History
Post by
culturedpiggy01
on Nov 26, 2021 2:23pm
$ACOG.V ceo talks new treatment for Alzheimer's symptoms
great video of $ACOG.V CEO talking about possible treatments in development for treating the symptoms of Alzheimer’s https://www.youtube.com/watch?v=4S4g1dVckN8 he also added that results from its
...more
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(26)
•••
XeniaTechie
X
View Profile
View Bullboard History
Post by
XeniaTechie
on Nov 25, 2021 2:24pm
Alpha Cognition CEO talks update on clinical programs
Don't miss this update with $ACOG CEO, providing an update on clinical programs. Consider these catalysts moving into '22 - top line data read out expected in Q1/2 '22, patient
...more
(144)
•••
culturedpiggy01
X
View Profile
View Bullboard History
Post by
culturedpiggy01
on Nov 24, 2021 2:01pm
updates on $ACOG.V
I've been following $ACOG.V for a while now and I have to mention, their approach towards finding better treatments for neurodegenerative diseases, specially the ones under served like Alzheimer’s
...more
(273)
•••
partystocker
X
View Profile
View Bullboard History
Post by
partystocker
on Nov 23, 2021 2:56pm
$ACOG Prices Approaching Descending Triangle Completion
Shares of Alpha Cognition $ACOG/$ACOG.V are forming into a strong downward triangle pattern as their bearish trend slows. As price action continues to consolidate towards $1.12 I’m watching closely
...more
(144)
•••
culturedpiggy01
X
View Profile
View Bullboard History
Post by
culturedpiggy01
on Nov 22, 2021 1:51pm
Updates on $ACOG.V
good to see $ACOG.V in the green today, its been a while since we've received new updates from Alpha. neurodegenerative diseases are a continuing core area for new studies and trials to find
...more
(273)
•••
partystocker
X
View Profile
View Bullboard History
Post by
partystocker
on Nov 21, 2021 9:50pm
$ACOG pretty quiet lately
Shares of Alpha Cognition have really begun to see a decrease in volatility and consolidate into support at $1.12. I think we can expect to see a continued downward consolidation towards
...more
(21)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Nov 18, 2021 6:29pm
Drugs like ACOG's keep ALZ patients out of care homes
Alpha Cognition Inc. ( $ACOG.V $ACOGF ) is developing medicines for the treatment of ALS, Alzheimer's and other under-served neurodegenerative diseases. One of the drugs they are developing
...more
(26)
•••
XeniaTechie
X
View Profile
View Bullboard History
Post by
XeniaTechie
on Nov 17, 2021 12:44pm
Watch the Alpha Cognition presentation from the Q4 Investors
Alpha Cognition CEO Michael McFadden presented this morning at the Q4 Investors Summit Group. This was a highly informative session that presented significant lab studies, data and commercialization
...more
(21)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Nov 16, 2021 5:40pm
$ACOG DD
Interested in investing in a company that is developing ALS and Alzheimer's treatments? Alpha Cognition Inc. ( $ACOG.V ACOGF ) is in the clinical stages of developing medicines for the
...more
(21)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Nov 15, 2021 6:14pm
$ACOG developing ALS and Dementia treatment
I'm always happy to put my money in a company that is going to do good in the world as well as do good on the market. Alpha Cognition Inc. ( $ACOG.V ACOGF ) is in the clinical stages of developing
...more
(8)
•••
thelordofstocks
X
View Profile
View Bullboard History
Post by
thelordofstocks
on Nov 12, 2021 1:25pm
Long-term potential
I am optimistic that $ACOG's treatment could become widely available fast, especially considering how large the market is for Alzheimer's and ALS treatment is. Alzheimer's healthcare costs
...more
(16)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Nov 11, 2021 4:54pm
$ACOG presenting at Q4 Virtual Summit on November 17th!
Alpha Cognition Inc. ($ACOG $ACOG.v $ACOGF) will be presenting at the Q4 Virtual Summit hosted by the Investors Summit Group. $ACOG is scheduled to present at 10:15 AM ET on November 17th, 2021.
...more
(26)
•••
XeniaTechie
X
View Profile
View Bullboard History
Post by
XeniaTechie
on Nov 10, 2021 12:14pm
ACOG presentation at Virtual Investors Summit Group Q4 event
Alpha Cognition will be presenting at this year's Q4 Virtual Summit hosted by Investors Summit Group. This will be an opportunity to see the recent developments and successes on this significant
...more
(1)
•••
SkywalkerofLuke
X
View Profile
View Bullboard History
Post by
SkywalkerofLuke
on Nov 09, 2021 3:30pm
$ACOG Presentation On Nov 12
$ACOG $ACOG.v announced yesterday that it will be presenting at the 14th annual LD Micro Main Event on Nov 12th @ 3pm EST in LA, which will also be live streamed. Presentation will see the
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments